No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests.
Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts:
As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson's disease, strokes and tumors.
The neurological exam may test:
If MCI is thought to be due to mild Alzheimer's disease, tests can check for biomarkers. Biomarkers of Alzheimer's disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer's disease.
Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone.
Blood tests also can check for proteins in the brain that are related to Alzheimer's disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer's disease. This test may confirm Alzheimer's as a cause of cognitive impairment.
An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer's disease.
Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions.
Longer forms of the tests look at how a person's mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.
Treatment for mild cognitive impairment may include medicines for Alzheimer's disease. If memory symptoms are being caused by medicines or health conditions, treatment involves addressing those issues.
Mild cognitive impairment, also known as MCI, is an active area of research. Clinical studies are being conducted to better understand the condition and find treatments to improve symptoms or prevent or delay dementia.
Your healthcare professional may recommend medicines approved by the Food and Drug Administration (FDA) to slow the decline in thinking and mental abilities. The medicines can help prevent proteins from clumping and forming structures known as amyloid plaques in the brain. Before starting treatment, the FDA recommends getting a brain MRI.
The medicines are approved for people with mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease. Known as monoclonal antibodies, they include:
These medicines also can have more-serious side effects. Lecanemab or donanemab can cause swelling in the brain or small bleeds in the brain. Rarely, brain swelling can cause seizures or other symptoms, or even death.
People with a form of a gene known as APOE e4 appear to be at higher risk of serious side effects. The FDA recommends that you get tested for the gene before starting treatment. Once you're taking the medicine, regular brain MRIs monitor for brain swelling and bleeding.
Blood thinners also can raise the risk of bleeding in the brain when taking these medicines. Talk to your healthcare professional if you take a blood thinner before you take lecanemab or donanemab. Also talk to your healthcare professional if you have other risk factors of bleeding in the brain.
Research on other potential side effects of these medicines is ongoing.
Researchers also are studying how effective the medicines may be for people at risk of Alzheimer's disease. This includes first-degree relatives of people with the disease, such as a parent or sibling.
If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren't recommended for routine treatment of MCI. They haven't been found to help prevent dementia, and they can cause side effects.
Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. Discuss any side effects with your healthcare team. Never stop taking your medicine unless your healthcare professional tells you to do so. These medicines include:
Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability. Conditions that can affect memory include:
Study results have been mixed about whether diet, exercise or other healthy lifestyle choices can prevent or reverse mild cognitive impairment. Regardless, these healthy choices promote good overall health and may play a role in good brain health.
You're likely to start by seeing your healthcare professional. If it's suspected that you have memory changes, you may be referred to a specialist. This specialist may be a neurologist, psychiatrist or neuropsychologist.
Because appointments can be brief and there's often a lot to talk about, it's good to be well prepared. Here are some ideas to help you get ready for your appointment and know what to expect.
List your questions from most pressing to least important in case time runs out. For mild cognitive impairment, some questions to ask include:
Ask any other questions to clarify anything you don't understand.
Your healthcare professional is likely to have questions for you, including:
Some supplements have been suggested to help prevent or delay mild cognitive impairment. However, more research is needed in this area. Talk to a member of your healthcare team before taking supplements because they can interact with your current medicines.